We are live on ! Find out more
SCPH

scPharmaceuticals

Delisted

SCPH was delisted on the 6th of October, 2025.

26 hedge funds and large institutions have $44.5M invested in scPharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $23.5M → $44.5M (+$21M)

1.11% more ownership

Funds ownership: 39.67%40.78% (+1.1%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

16% less funds holding

Funds holding: 3126 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
7
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
-$108K -33,780 Closed
PP
27
Paloma Partners
Connecticut
-$96K -30,000 Closed
SG Americas Securities
28
SG Americas Securities
New York
-$41K -12,877 Closed
UBS Group
29
UBS Group
Switzerland
-$13K -4,211 Closed
Macquarie Group
30
Macquarie Group
Australia
-$11K -3,486 Closed
TRCT
31
Tower Research Capital (TRC)
New York
-$10K -3,211 Closed
Deutsche Bank
32
Deutsche Bank
Germany
-$5K -1,830 Closed
Legal & General Group
33
Legal & General Group
United Kingdom
-$4K -1,265 Closed
Wells Fargo
34
Wells Fargo
California
-$1K -411 Closed